Patent applications and USPTO patent grants for ConjuChem, Inc..The latest application filed is for "long lasting synthetic glucagon like peptide (glp-1)".
Patent | Date |
---|---|
Long lasting anti-angiogenic peptides Grant 7,144,854 - Bridon , et al. December 5, 2 | 2006-12-05 |
Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders Grant 7,112,567 - Bridon , et al. September 26, 2 | 2006-09-26 |
Long lasting fusion peptide inhibitors of viral infection Grant 7,090,851 - Bridon , et al. August 15, 2 | 2006-08-15 |
Long lasting synthetic glucagon like peptide (GLP-1) App 20060135426 - Bridon; Dominique P. ;   et al. | 2006-06-22 |
Long lasting synthetic glucagon like peptide (GLP-1) App 20060058235 - Bridon; Dominique P. ;   et al. | 2006-03-16 |
Long lasting synthetic glucagon like peptide (GLP-1) App 20060009377 - Bridon; Dominique P. ;   et al. | 2006-01-12 |
Method for purification of albumin conjugates App 20050267293 - Bousquet-Gagnon, Nathalie ;   et al. | 2005-12-01 |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components App 20050187159 - Bridon, Dominique P. ;   et al. | 2005-08-25 |
Long lasting natriuretic peptide derivatives App 20050176641 - Bakis, Peter ;   et al. | 2005-08-11 |
Anti-obesity agents App 20050176643 - Bridon, Dominique P. ;   et al. | 2005-08-11 |
Long lasting synthetic glucagon-like peptide {GLP-1} Grant 6,887,849 - Bridon , et al. May 3, 2 | 2005-05-03 |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components Grant 6,887,470 - Bridon , et al. May 3, 2 | 2005-05-03 |
Long lasting fusion peptide inhibitors of viral infection App 20050070475 - Bridon, Dominique P. ;   et al. | 2005-03-31 |
Affinity markers for human serum albumin App 20050037974 - Krantz, Alexander ;   et al. | 2005-02-17 |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components Grant 6,849,714 - Bridon , et al. February 1, 2 | 2005-02-01 |
Long lasting synthetic glucagon-like peptide (GLP-1) Grant 6,821,949 - Bridon , et al. November 23, 2 | 2004-11-23 |
Pulmonary delivery for bioconjugation App 20040156859 - Ezrin, Alan M. ;   et al. | 2004-08-12 |
Long lasting synthetic glucagon like peptide (GLP-1) App 20040138100 - Bridon, Dominique ;   et al. | 2004-07-15 |
Long lasting synthetic glucagon like peptide (GLP-1) App 20040127398 - Bridon, Dominique P. ;   et al. | 2004-07-01 |
Pulmonary delivery for bioconjugation Grant 6,706,892 - Ezrin , et al. March 16, 2 | 2004-03-16 |
Method for alleviating pain or providing an analgesic effect in a patient Grant 6,610,825 - Ezrin , et al. August 26, 2 | 2003-08-26 |
Antinociceptive agent derivative Grant 6,602,981 - Ezrin , et al. August 5, 2 | 2003-08-05 |
Long lasting insulinotropic peptides Grant 6,593,295 - Bridon , et al. July 15, 2 | 2003-07-15 |
Long lasting synthetic glucagon like peptide {GLP-!} Grant 6,514,500 - Bridon , et al. February 4, 2 | 2003-02-04 |
Conjugate comprising an antinociceptive agent covalently bonded to a blood component Grant 6,500,918 - Ezrin , et al. December 31, 2 | 2002-12-31 |
Long lasting insulinotropic peptides Grant 6,329,336 - Bridon , et al. December 11, 2 | 2001-12-11 |
Affinity labeling libraries and applications thereof Grant 6,277,583 - Krantz , et al. August 21, 2 | 2001-08-21 |
Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes Grant 6,277,863 - Krantz , et al. August 21, 2 | 2001-08-21 |
Extended lifetimes in vivo renin inhibitors Grant 6,107,489 - Krantz , et al. August 22, 2 | 2000-08-22 |
Cellular and serum protein anchors and conjugates Grant 6,103,233 - Pouletty , et al. August 15, 2 | 2000-08-15 |
Methods of treating or preventing thromboses Grant 6,087,375 - Bridon , et al. July 11, 2 | 2000-07-11 |
Methods for producing novel conjugates of thrombin inhibitors Grant 5,942,620 - Krantz , et al. August 24, 1 | 1999-08-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.